Granules India's net profit declines 6% due to FDA inspection, lower demand; revenue from North America rises to 77%.

On January 24, several companies, including Indigo, JSW Steel, and AU Small Finance Bank, will announce their Q3 earnings, as per the BSE calendar.

India's Torrent Pharmaceuticals reported a smaller-than-expected third-quarter profit on Friday, hurt by the planned closure of its insulin manufacturing facility. The company, known for ...

The company, known for its calcium supplement Shelcal 500, reported a near 14% rise in consolidated net profit to Rs 503 ...

Granules India shares declined beyond 3.5 percent on Friday, January 24, following the announcement of its weak Q3FY25 ...

Granules India’s net profit declined 6 per cent at ₹117 crore in the third quarter ended December 2024 compared to ₹125 crore ...

Granules India slipped 2.85% to Rs 583.15 after its consolidated net profit fell 6.41% to Rs 117.60 crore on 1.55% decline in total revenue from operations to Rs 1,137.70 crore in Q3 FY25 over Q3 FY24 ...

Shares of Granules India Ltd. fell sharply on Friday after the pharmaceutical company reported a decline in its revenue and ...

Granules India's revenue decreased by 1.6% year-on-year for the three months ended Dec. 31, 2024, reaching Rs 1,138 crore.

Granules India reported a drop in third-quarter profit on Friday, hurt by pricing pressure in its key European market.